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Abstract
Influenza-associated excess mortality is widely used to assess the severity of influenza epidemics.
In Germany, however, it is not yet established as a routine component of influenza surveillance. We
therefore applied a simple method based on the annual distribution of monthly relative mortality
(relative mortality distribution method, RMDM) to a time-series of German monthly all-cause
mortality data from 1985–2001 to estimate influenza-associated excess mortality. Results were
compared to those obtained by cyclical regression.
Both methods distinguished stronger from milder influenza seasons, but RMDM gave the better fit
(R2 = 0.80). For the years after reunification, i.e. 1990/91 through 2000/01, RMDM yielded an
average of 6900 (conservative estimate) to13600 influenza-asssociated excess deaths per season
(crude estimate). The most severe epidemics occurred during subtype A/H3N2 seasons. While
German all-cause mortality declined over the study period, the number of excess deaths displayed
an upward trend, coinciding with an increase of the proportion of the elderly population.
Introduction
In the Northern hemisphere, influenza is a seasonal dis-
ease with high epidemic potential. Excess mortality due to
influenza is frequently used as one important parameter
to assess the severity of epidemics [1].
In non-pandemic years, influenza-associated death is
mainly restricted to the elderly and people with underly-
ing chronic illnesses [2,3]. However, analyses of death cer-
tificates show that clinicians often do not attribute
influenza-related deaths to influenza, but rather to a pre-
existing underlying condition. Influenza-associated
deaths may therefore be hidden not only among cases of
pneumonia but among other causes of death such as car-
diovascular events or metabolic disorders [4]. Hence, all-
cause mortality has been found to be more complete and
accurate for assessing the total impact of influenza on
mortality [1].
Conceptually, influenza-associated excess mortality is
estimated as the difference between observed mortality
during the influenza season and baseline values to be
expected during that time span if influenza were absent.
Different approaches to obtain estimates of the baseline
have included cyclical regression [5,6], Poisson regression
[4], multiple linear regression [7,8] and autoregressive
integrated moving average (ARIMA) models [9].
In Germany, an influenza sentinel surveillance system was
established in August 1992 (Arbeitsgemeinschaft Influ-
enza: AGI). It consists of a nationwide network of private
practice physicians who report data on acute respiratory
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infections and send throat swabs from a sample of
patients to the Influenza Reference Laboratory for virus
isolation and typing [10]. Before August 1992, German
influenza surveillance relied exclusively on reference lab-
oratory results, was based on fewer samples and included
a considerable proportion of hospital patients in addition
to patients seen by private physicians [11]. The current
system uses excess incidence of physician consultations
and hospitalisations due to acute respiratory infections to
assess the severity of influenza seasons. Mortality data
have not been analysed routinely, partly because German
vital statistics become available with at least six months
delay. As a step towards the incorporation of mortality
data into monitoring the impact of influenza in Germany,
we applied two types of models to a time-series of German
all-cause mortality data from January 1985 through
December 2001: cyclical regression and a method based
on the distribution of monthly relative mortality (relative
mortality distribution model, RMDM). Besides estimating
excess mortality linked to influenza in Germany, our goal
was to evaluate the two approaches in terms of simplicity,
practicality and goodness-of-fit.
Methods
Data source and software
We obtained all-cause mortality data by month of report
from 1985 to 2001 and population data for the same time
period from the German National Bureau of Statistics.
Weekly data or age-stratified monthly data were not avail-
able. We adjusted for the variable length of months by
dividing each value by that month's number of days, mul-
tiplying by 365 and dividing by 12. For the period January
1985 through December 1990, we used only West Ger-
man mortality data in the analyses because East German
data were incomplete. For the period from January 1991
onwards, i.e. after reunification in October 1990, we used
data from the entire country. Virologic surveillance data
from the German Influenza Reference Laboratory served
to identify months with influenza activity between Janu-
ary 1985 and August 1992. After August 1992, morbidity
data from the then founded sentinel influenza surveil-
lance system were additionally available.
All analyses were done using Microsoft Excel 97 (Red-
mond, WA, USA).
Cyclical regression
We used a "Fast Fourier Transform" to identify significant
cyclical components in our time-series. As this procedure
requires powers of 2 for the number of data-points, we
looked at two overlapping time periods of 128 months
each from January 1985 through August 1995 and from
January 1991 through August 2001. In each of the two
time-series, stationarity had to be achieved for any further
modelling. Therefore the variance was stabilized by log
transformation and the linear trend removed by linear
regression and subtraction. We then used a least squares
approach to fit a cosine curve described by the equation
t = a + bt + ∑Rcos(ωt + θ)
where   is the expected all-cause mortality, a and b are
intercept and slope, respectively, of a linear term, t is the
index for month of reported death, R is the amplitude of
the periodic variation, ω is its frequency and θ is the
phase.
From this model, we omitted any month for which sur-
veillance had indicated influenza activity and during
which observed mortality exceeded modelled mortality.
Refitting of the model yielded baseline all-cause mortality
values which would be expected in the absence of influ-
enza activity. 90% CI were calculated based on the stand-
ard deviation of the residuals according to the formula
where  t is the expected all-cause mortality in a given
month t, yOis any mortality observed during the study
period, yE is any mortality expected in the same month as
yO, n is the number of observations and dof is the number
of degrees of freedom.
Data were finally restored to their original state by adding
the linear trend that had initially been subtracted, fol-
lowed by exponential transformation. The fit of the model
with baseline mortality was assessed by the coefficient of
determination, R2.
Relative mortality distribution model
The time period under study was January 1985 through
August 2001. We observed that during this period the
ratios of each month's mortality and that year's average
mortality (= relative mortality) followed a fairly constant
pattern (Figure 1). We calculated the mean relative mor-
tality of all corresponding months across the years stud-
ied. Expected mortality for any given month could then be
modelled by multiplying the respective mean with the
total mortality observed in that year. Months in which
influenza activity was reported and in which observed
mortality exceeded the model values were omitted and
mean monthly percentages recalculated by minimising
the residuals for the remaining months. This step was
repeated a second time resulting in the final model of
baseline mortality. Upper and lower 90% confidence
intervals (CI) were calculated based on the standard devi-
ation of the residuals as described for cyclical regression.
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Again, the fit of the model with baseline mortality was
assessed by the coefficient of determination, R2.
Excess mortality computation and further analyses
The principle was the same for both approaches. Influ-
enza-associated excess mortality for each season was esti-
mated as the sum of all positive monthly excess values
(i.e. observed minus expected mortality after refitting of
the model) within the period of increased influenza activ-
ity as indicated by surveillance data. In addition to this
crude estimate, a more conservative estimate was
obtained by subtracting the upper 90% confidence limits
instead of the model point estimates from the observed
mortality values.
We compared estimates by influenza season, estimation
approach and influenza type/subtype. Type/subtype-spe-
cific excess mortality was assumed to correspond to a
type/subtype's proportion among human isolates within
a given season. Type/subtype-specific average seasonal
excess mortality was estimated based on seasons in which
a type/subtype predominated, i.e. accounted for more
than 50% of the seasonal total of human isolates.
The number of influenza-associated excess deaths was
estimated using the RMD model that was developed for
the entire time span (1985–2001). However, as reunifica-
tion enlarged the study population by about 25%, calcu-
lations were restricted to unified Germany from January
1991 until August 2001.
Results
Between January 1985 and August 2001, seasonal influ-
enza activity had occurred in Germany almost annually
during one or more months between December and April.
Annual distribution of monthly all-cause mortality relative to the yearly average mortality, West Germany (1985 – 1990) and  unified Germany (1991 – 2001) Figure 1
Annual distribution of monthly all-cause mortality relative to the yearly average mortality, West Germany (1985 – 1990) and 
unified Germany (1991 – 2001).Emerging Themes in Epidemiology 2005, 2:6 http://www.ete-online.com/content/2/1/6
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The adjusted monthly all-cause mortality ranged between
76 and 113 per 100,000 population and followed a sea-
sonal pattern peaking in winter months.
Fourier analysis of observed mortality indicated one cycli-
cal component of 12 months length for both the period
January 1985 through August 1995 and the period Janu-
ary 1991 through August 2001. R2 values obtained by
cyclical regression were 0.71 and 0.73 for the first and sec-
ond study period, respectively. The resulting models led to
average seasonal excess mortality estimates of 16.1 and
17.4 deaths per 100,000 population for the first and sec-
ond study period, respectively. Seasonal estimates ranged
between 2.2 and 44.2 excess deaths per 100,000 popula-
tion (Table 1). Conservative estimates averaged at 6.8 and
7.7 deaths per 100,000 population and season for the first
and second study period, respectively (range: 0 to 25.8).
The difference between the crude and conservative esti-
mate was 10.3 per 100,000 population (61% of the crude
estimate) for the period 1985–1995 and 12.0 per 100,000
population (62% of the crude estimate) for the period
1991–2001. Figure 2 shows a graphic representation of
cyclical regression applied to the period 1985–1995.
Applying RMDM to the period 1985–2001 gave an R2
value of 0.80 for the total period. If calculated separately
for the two periods as studied by cyclical regression, R2
was 0.72 for the first and 0.80 for the second period. Esti-
mated average seasonal influenza-associated excess mor-
tality amounted to 16.0 (range: 2.9 to 40.6) excess deaths
per 100,000 population. The conservative estimate was
7.8 (range: 0 to 26.1) deaths per 100,000 population
(table 1). The difference between the two estimates was
8.2 per 100,000 population (51% of the crude estimate).
Figure 3 displays the modelled influenza-free mortality
and the observed mortality from 1985–2001.
In most seasons, especially those with high excess mortal-
ity, the methods yielded similar crude estimates. Compar-
ing total excess mortality over the two 10-year periods that
were required for cyclical regression, RMDM crude esti-
mates were lower (145.2 vs. 176.7 and 183.2 vs. 190.9).
For the period 1985–1995 RMDM also yielded a lower
conservative estimate (61.6 vs. 74.3) while for the second
period it was higher (92.9 vs. 84.4) than the one obtained
by cyclical regression.
Table 1: Influenza-associated excess mortality per 100,000 population in West Germany (1984/85–1989/90) and united Germany 
(1990/91–2000/01), by method of estimation
Cyclical Regression Relative Mortality Distribution
Influenza season Crude estimatea conservativeb Crude estimatea conservativeb
1984 / 85c 17.9 3.2 22.0 8.7
1985 / 86c 25.4 12.9 23.4 13.9
1986 / 87c 9.3 1.8 2.9 0.0
1987 / 88c 2.2 0.0 3.5 0.0
1988 / 89c 10.3 3.9 5.9 0.0
1989 / 90c 35.7 17.0 30.8 16.3
1990 / 91 7.4 / 5.9 d 1.5 / 0 d 4.6 0.1
1991 / 92 21.8 / 19.6 d 12.6 / 11.1 d 15.8 4.2
1992 / 93 21.2 / 21.4 d 11.2 / 11.2 d 18.9 12.3
1993 / 94 16.5 / 16.6 d 9.0 / 8.8 d 7.8 2.8
1994 / 95 9.0 / 11.7 d 1.2 / 2.4 d 9.7 3.4
1995 / 96 44.2 25.8 40.6 26.1
1996 7 97 8.0 1.0 15.0 5.5
1997 / 98 10.9 1.2 11.3 2.6
1998 / 99 26.9 15.4 26.7 19.3
1999 / 2000 12.9 5.5 19.3 9.6
2000 / 01 12.7 2.0 13.5 7.0
1984/85–1994/95 176.7 74.3 145.2 61.6
1990/91–2000/01 190.9 84.4 183.2 92.9
1984/85–2000/01 292.3 / 291.6 125.2 / 123.2 271.7 131.8
a observed minus expected mortality
b observed minus upper 90%confidence limit of expected mortality
c West German excess mortality only
d For cyclical regression two models were built, one for the time period 1984/85–1994/95 and one for 1990/91–2000/01, resulting in two estimates 
for the seasons 1990/91–1994/95Emerging Themes in Epidemiology 2005, 2:6 http://www.ete-online.com/content/2/1/6
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In 9 of the 17 influenza seasons, Influenza A/H3N2
accounted for more than 50% of human isolates at the
National Reference Laboratory and caused an estimated
average mortality of 15.4 per 100,000 population in those
seasons (Table 2). Three seasons were dominated by
Influenza A/H1N1 (average mortality 6.7 per 100,000)
and 5 seasons by Influenza B (average mortality 11.8 per
100,000).
The overall number of excess deaths for the period 1990/
91–2001 from RMDM (Table 3) was between 3670 and
33234 influenza-associated excess deaths for the crude
estimate and between 60 and 21365 for the conservative
estimate. The average number of excess deaths for the 11
seasons was estimated to lie between 6906 (conservative
estimate) and 13601 (crude estimate).
Between 1984/85 and 2000/01 excess mortality peaked
roughly every four to five years and showed a rising trend
in parallel with the proportion of the population over 60
years of age (Figure 4). The two largest peaks were due to
influenza A/H3N2, and were detected by both approaches
including the conservative estimates.
Discussion
This paper presents a systematic account of recent influ-
enza-associated excess mortality in Germany. For the dec-
ade following reunification, the average seasonal number
of excess deaths due to influenza ranged between 6906
(conservative estimate) and 13601 (crude estimate), with
the most severe epidemics associated with the A/H3N2
subtype.
While German all-cause mortality declined over the study
period, excess deaths appeared to have been rising. This
increase seemingly contradicts the growing number of
sold doses of influenza vaccine in Germany [12]. How-
ever, during the same time period the proportion of the
elderly in the German population has also increased and
may be the underlying factor that is driving excess deaths.
A similar explanation for equally paradox trends was sug-
gested in a recent analysis of US mortality data [13].
Observed mortality and mortality to be expected in the absence of influenza, as estimated by cyclical regression, West Ger- many (1985 – 1990) and unified Germany (1991 – 2001) Figure 2
Observed mortality and mortality to be expected in the absence of influenza, as estimated by cyclical regression, West Ger-
many (1985 – 1990) and unified Germany (1991 – 2001).Emerging Themes in Epidemiology 2005, 2:6 http://www.ete-online.com/content/2/1/6
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Observed mortality and mortality to be expected in the absence of influenza, as estimated by a the relative mortality distribu- tion approach, West Germany (1985 – 1990) and unified Germany (1991 – 2001) Figure 3
Observed mortality and mortality to be expected in the absence of influenza, as estimated by a the relative mortality distribu-
tion approach, West Germany (1985 – 1990) and unified Germany (1991 – 2001).
Table 2: Influenza-associated excess deaths per 100,000 population in West Germany (1984/85–1989/90) and united Germany (1990/
91–2000/01), estimated by relative mortality distribution modelling (crude approach) and stratified by influenza type/subtype. Excess 
mortality figures are only displayed for the seasonally predominating type/subtype (>50% of human isolates).
A/H3N2 A/H1N1 B
Influenza season Total EM % of isolates EM % of isolates EM % of isolates EM
1984 / 85 22.0 97 21.4 1 2
1985 / 86 23.4 1 0 99 23.1
1986 / 87 2.9 0 97 2.8 3
1987 / 88 3.5 100 3.5 0 0
1988 / 89 5.9 19 76 4.5 4
1989 / 90 30.8 82 25.3 0 18
1990 / 91 4.6 0 15 85 3.9
1991 / 92 15.8 69 10.8 31 0
1992 / 93 18.9 16 0 84 15.8
1993 / 94 7.8 100 7.8 0 0
1994 / 95 9.7 19 2 79 7.7
1995 / 96 40.6 55 22.4 42 3
1996 7 97 15.0 39 6 55 8.2
1997 / 98 11.3 96 10.5 7 1
1998 / 99 26.7 67 17.9 0 33
1999 / 2000 19.3 99 19.0 1 0
2000 / 01 13.5 0 95 12.9 5
Averagea 15.4 6.7 11.8
a Excess mortalityEmerging Themes in Epidemiology 2005, 2:6 http://www.ete-online.com/content/2/1/6
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The two methods were able to differentiate severe influ-
enza seasons from mild ones detecting excess mortality
peaks in 1989/90 and 1995/96 which were also the influ-
enza seasons with the highest morbidity during the study
period.
Cyclical regression is an established technique for time-
series analysis and has been one of the methods used by
the U.S. Centers for Disease Control and Prevention to
estimate influenza-associated excess mortality [6]. It
requires an understanding of trigonometrics and may not
be straightforward to apply for non-epidemiologists or
non-statisticians.
The modelling approach that is based on the annually
recurring pattern of relative mortality distribution is sim-
ple, practical and yields excess mortality estimates in line
with those obtained by cyclical regression. Unlike Fourier
cyclical regression, however, it neither requires a certain
number of time units nor was it necessary to assume linear
trends in annual mortality. Because variations of year-to-
year estimates may not be linear, the model relies only on
the average annual mortality and is therefore more flexi-
ble than the cyclical regression model.
The methods yielded crude excess estimates that were not
very far apart. As the exact extent of influenza-associated
excess mortality is unknown, the accuracy of the estima-
tions could not serve to evaluate the approaches. The
goodness-of-fit of RMDM was slightly superior and the
Dominant influenza strains (>50% of isolates), influenza-associated excess deaths per 100000 population and season, by estima- tion method, and proportion of population over 60 years, West Germany (1985 – 1990) and unified Germany (1991 – 2001) Figure 4
Dominant influenza strains (>50% of isolates), influenza-associated excess deaths per 100000 population and season, by estima-
tion method, and proportion of population over 60 years, West Germany (1985 – 1990) and unified Germany (1991 – 2001).
Table 3: Influenza-associated excess deaths in Germany, 1991–
2001, estimated by relative mortality distribution modelling
Influenza season Crude estimatea Conservativeb
1990 / 91 3670 60
1991 / 92 12676 3345
1992 / 93 15281 10003
1993 / 94 6304 2241
1994 / 95 7911 2738
1995 / 96 33234 21365
1996 / 97 12338 4535
1997 / 98 9296 2172
1998 / 99 21907 15854
1999 / 00 15854 7896
2000 / 01 11136 5757
Total 138471 70209
Average 13601 6906
a observed number of deaths minus expected number of deaths
b observed number of deaths minus upper 90% confidence limit of 
expected number of deathsEmerging Themes in Epidemiology 2005, 2:6 http://www.ete-online.com/content/2/1/6
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approach seemed better than cyclical regression at captur-
ing irregularities of the mortality curve every December
and January, that are probably due to holiday season-
associated delays in death registration by time of report
(Fig. 2 and 3). Although the better fit may be explained by
the larger number of parameters included in the model,
the easier handling and higher flexibility made us favour
RMDM.
The influenza-associated seasonal excess mortality of 16
per 100,000 population that we obtained for Germany
using the RMDM was plausible when compared with pre-
viously published numbers from other countries.
Researchers in the Netherlands, the USA and Switzerland
estimated for their countries an influenza-related annual
mortality of 14, 19.6 and 21.6 per 100,000 population,
respectively [4,13,14].
So far, mortality data have not been incorporated in the
routine surveillance of influenza in Germany since they
become available only after a lag of up to one year. How-
ever, mortality data are not only necessary to calculate the
burden of influenza for a given season but may also serve
as an efficient surveillance tool [15] in particular for pan-
demic situations. We found that the more severe influenza
seasons in Germany were associated with predominance
of A/H3N2 followed by B and A/H1N1. This general trend
is in line with the findings of Thompson in the USA [13].
The weak effects of A/H1N1 seasons have probably to do
with the fact that this subtype has been circulating contin-
uously since 1918 except for an interval between 1957
and 1977. It had thus ample time to adapt to the human
population and vice versa.
The study has the following limitations. As influenza sea-
sons usually last six to ten weeks with a peak phase of one
to three weeks, we would have ideally preferred to use
weekly mortality data. However, only monthly mortality
data were available from the German National Bureau of
Statistics. The use of weekly data might have increased
model resolution and thus estimate precision.
To minimize the likelihood of taking deaths into account
which were rather due to winter-related causes other than
influenza, we attributed excess mortality to influenza only
if it occurred during months with influenza activity as
indicated by sentinel and virologic surveillance data.
However, an important alternative cause of death during
influenza seasons is respiratory syncytial virus (RSV)
infection [13,16]. The RSV seasons from 1994/95 to
1996/97 started late (December to January) and ended
between March and May. From 1997/98 to 2001, it seems
that late and early seasons (start in September to October)
have been alternating [17]. These data indicate that over-
lap between RSV and influenza seasons and thus overesti-
mation of influenza-associated excess mortality cannot be
ruled out
We fitted the initial models to the entire time-series
including epidemic months. This might have led to some
overestimation of expected and underestimation of influ-
enza-associated excess mortality, but this method has
been used previously [1,18]. Furthermore, although we
tried to model expected mortality by removing all months
with excess mortality, we may have falsely retained some
months in which influenza-associated mortality was
present, thereby again overestimating expected and
underestimating excess mortality. On the other hand, two
factors may have caused some overestimation of influ-
enza-associated excess mortality. First, the use of all-cause
mortality is likely to take deaths into account that are not
related to influenza [13]. Second, the approach of
ignoring negative "excess" may entail contributions to
excess mortality from positive random deviations that
would have otherwise been cancelled out by negative ran-
dom deviations.
Finally, our estimates are across all age-groups as age-spe-
cific mortality data were not available. Age-specific data
would not only improve the quality of the models and the
estimates, but would also allow to target public health
messages more precisely. For the future, timely, weekly
and age-specific mortality data are highly desirable to
build better models, calculate burden of disease more
precisely and allow integration into routine influenza
surveillance.
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